 David Orlicky
Concepts (967)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Liver | 56 | 2025 | 1826 | 2.990 |
Why?
| | Pelvic Organ Prolapse | 4 | 2024 | 45 | 2.400 |
Why?
| | Ligaments | 4 | 2024 | 54 | 1.910 |
Why?
| | Cholestasis | 12 | 2023 | 228 | 1.720 |
Why?
| | Mice | 133 | 2025 | 16602 | 1.710 |
Why?
| | Mice, Inbred C57BL | 68 | 2025 | 5272 | 1.560 |
Why?
| | Non-alcoholic Fatty Liver Disease | 10 | 2022 | 258 | 1.500 |
Why?
| | Animals | 182 | 2025 | 34479 | 1.460 |
Why?
| | Ethanol | 19 | 2023 | 584 | 1.440 |
Why?
| | Lipid Metabolism | 18 | 2020 | 491 | 1.440 |
Why?
| | Hepatocytes | 10 | 2024 | 213 | 1.370 |
Why?
| | Liver Diseases, Alcoholic | 10 | 2022 | 89 | 1.230 |
Why?
| | Perilipin-2 | 13 | 2019 | 36 | 1.220 |
Why?
| | Oxidative Stress | 26 | 2024 | 1176 | 1.210 |
Why?
| | Mice, Knockout | 39 | 2025 | 2755 | 1.130 |
Why?
| | Fatty Liver | 13 | 2024 | 231 | 1.120 |
Why?
| | Mast Cells | 5 | 2024 | 142 | 1.020 |
Why?
| | Uterus | 5 | 2024 | 206 | 1.010 |
Why?
| | Receptors, Prostaglandin | 13 | 1998 | 21 | 0.970 |
Why?
| | Bile Acids and Salts | 10 | 2024 | 194 | 0.950 |
Why?
| | Fructose | 10 | 2024 | 106 | 0.940 |
Why?
| | Obesity | 15 | 2023 | 2858 | 0.900 |
Why?
| | Dinoprost | 15 | 1996 | 30 | 0.890 |
Why?
| | Acetaminophen | 6 | 2022 | 243 | 0.850 |
Why?
| | Chemical and Drug Induced Liver Injury | 7 | 2024 | 132 | 0.830 |
Why?
| | Disease Models, Animal | 37 | 2025 | 3937 | 0.830 |
Why?
| | Fatty Liver, Alcoholic | 5 | 2021 | 16 | 0.820 |
Why?
| | Metabolic Syndrome | 7 | 2023 | 338 | 0.820 |
Why?
| | Inflammation | 19 | 2024 | 2654 | 0.730 |
Why?
| | Adipocytes | 6 | 2018 | 204 | 0.730 |
Why?
| | Kidney | 10 | 2024 | 1302 | 0.720 |
Why?
| | Aldehyde Dehydrogenase | 7 | 2017 | 105 | 0.710 |
Why?
| | Fructokinases | 8 | 2023 | 31 | 0.710 |
Why?
| | Receptors, Estrogen | 2 | 2023 | 424 | 0.690 |
Why?
| | Cytoplasm | 6 | 2016 | 257 | 0.690 |
Why?
| | Glutathione | 10 | 2025 | 334 | 0.670 |
Why?
| | Sacrum | 1 | 2020 | 74 | 0.670 |
Why?
| | Aldehydes | 10 | 2022 | 138 | 0.660 |
Why?
| | Protein Carbonylation | 8 | 2018 | 55 | 0.660 |
Why?
| | Milk | 7 | 2019 | 119 | 0.640 |
Why?
| | Liver Cirrhosis, Experimental | 1 | 2019 | 11 | 0.630 |
Why?
| | Liver Diseases | 6 | 2024 | 284 | 0.620 |
Why?
| | Fructose Intolerance | 3 | 2024 | 4 | 0.600 |
Why?
| | Dietary Fats | 5 | 2022 | 301 | 0.600 |
Why?
| | NF-kappa B | 7 | 2024 | 649 | 0.600 |
Why?
| | Chemical Warfare Agents | 6 | 2014 | 109 | 0.580 |
Why?
| | Liver Cirrhosis | 9 | 2025 | 275 | 0.580 |
Why?
| | Skin | 9 | 2019 | 718 | 0.570 |
Why?
| | Receptors, Cytoplasmic and Nuclear | 4 | 2021 | 215 | 0.570 |
Why?
| | Antioxidants | 10 | 2023 | 538 | 0.560 |
Why?
| | Neoplasm Proteins | 10 | 2005 | 421 | 0.550 |
Why?
| | Mechlorethamine | 5 | 2015 | 56 | 0.550 |
Why?
| | Cholangitis, Sclerosing | 4 | 2024 | 70 | 0.550 |
Why?
| | Lactation | 10 | 2019 | 170 | 0.530 |
Why?
| | Membrane Proteins | 12 | 2016 | 1105 | 0.520 |
Why?
| | Energy Metabolism | 7 | 2024 | 831 | 0.520 |
Why?
| | Carcinoma, Hepatocellular | 3 | 2025 | 270 | 0.520 |
Why?
| | Diet, High-Fat | 9 | 2020 | 238 | 0.510 |
Why?
| | Mammary Glands, Animal | 7 | 2019 | 124 | 0.510 |
Why?
| | Organelles | 2 | 2013 | 54 | 0.500 |
Why?
| | Male | 78 | 2025 | 62857 | 0.500 |
Why?
| | Burns | 3 | 2024 | 281 | 0.490 |
Why?
| | Signal Transduction | 16 | 2024 | 4826 | 0.490 |
Why?
| | Glutathione Transferase | 6 | 2019 | 99 | 0.490 |
Why?
| | Parenteral Nutrition | 5 | 2023 | 104 | 0.490 |
Why?
| | Dioxanes | 3 | 2024 | 6 | 0.470 |
Why?
| | DNA Damage | 8 | 2024 | 364 | 0.470 |
Why?
| | Mitochondria | 6 | 2019 | 848 | 0.460 |
Why?
| | PTEN Phosphohydrolase | 4 | 2018 | 157 | 0.450 |
Why?
| | Ovary | 4 | 2022 | 210 | 0.450 |
Why?
| | Immunity, Innate | 6 | 2024 | 802 | 0.440 |
Why?
| | Colon | 4 | 2024 | 248 | 0.430 |
Why?
| | Liver Neoplasms | 3 | 2025 | 633 | 0.430 |
Why?
| | Prostaglandins F | 6 | 1988 | 17 | 0.410 |
Why?
| | Endotoxemia | 2 | 2024 | 83 | 0.410 |
Why?
| | Alcohol Drinking | 4 | 2016 | 752 | 0.400 |
Why?
| | Macrophages | 7 | 2024 | 1460 | 0.400 |
Why?
| | Cytochrome P-450 CYP2E1 | 5 | 2024 | 24 | 0.390 |
Why?
| | Peptides | 3 | 2008 | 908 | 0.390 |
Why?
| | Tumor Necrosis Factor-alpha | 5 | 2024 | 1185 | 0.380 |
Why?
| | Alcoholic Intoxication | 2 | 2023 | 63 | 0.380 |
Why?
| | Receptors, Virus | 2 | 2003 | 83 | 0.380 |
Why?
| | Glutamate-Cysteine Ligase | 3 | 2025 | 18 | 0.380 |
Why?
| | Diabetic Nephropathies | 3 | 2024 | 278 | 0.370 |
Why?
| | Superoxide Dismutase | 6 | 2019 | 326 | 0.370 |
Why?
| | Transfection | 8 | 2016 | 893 | 0.370 |
Why?
| | Adenoviridae | 2 | 2003 | 189 | 0.360 |
Why?
| | Female | 61 | 2025 | 68153 | 0.360 |
Why?
| | Oxidation-Reduction | 7 | 2025 | 1001 | 0.360 |
Why?
| | Mustard Gas | 5 | 2014 | 104 | 0.360 |
Why?
| | Thioredoxin Reductase 1 | 3 | 2023 | 8 | 0.360 |
Why?
| | Down Syndrome | 3 | 2023 | 469 | 0.350 |
Why?
| | Lens, Crystalline | 2 | 2022 | 100 | 0.340 |
Why?
| | Endometrium | 6 | 1988 | 61 | 0.340 |
Why?
| | Inflammatory Bowel Diseases | 3 | 2020 | 311 | 0.340 |
Why?
| | Homocystinuria | 2 | 2024 | 69 | 0.340 |
Why?
| | Salmonella enterica | 2 | 2024 | 54 | 0.340 |
Why?
| | Diabetes Mellitus, Experimental | 3 | 2017 | 173 | 0.340 |
Why?
| | Humans | 70 | 2025 | 128417 | 0.330 |
Why?
| | Glutathione Reductase | 3 | 2019 | 23 | 0.330 |
Why?
| | Nitric Oxide Synthase Type I | 2 | 2020 | 28 | 0.330 |
Why?
| | Carcinoma, Basal Cell | 2 | 2022 | 73 | 0.330 |
Why?
| | Precancerous Conditions | 2 | 2023 | 161 | 0.330 |
Why?
| | Thioredoxins | 3 | 2018 | 28 | 0.330 |
Why?
| | Fructose-Bisphosphate Aldolase | 3 | 2024 | 8 | 0.320 |
Why?
| | AMP-Activated Protein Kinases | 4 | 2014 | 190 | 0.320 |
Why?
| | Lipids | 7 | 2019 | 620 | 0.310 |
Why?
| | Endothelial Cells | 2 | 2025 | 698 | 0.310 |
Why?
| | Taste | 2 | 2021 | 208 | 0.310 |
Why?
| | Rats | 18 | 2022 | 5165 | 0.310 |
Why?
| | Fallopian Tubes | 2 | 2022 | 30 | 0.310 |
Why?
| | Gene Expression Regulation, Enzymologic | 4 | 2021 | 281 | 0.300 |
Why?
| | Sevelamer | 2 | 2020 | 9 | 0.300 |
Why?
| | Lung Injury | 2 | 2021 | 199 | 0.300 |
Why?
| | Colitis | 2 | 2021 | 240 | 0.300 |
Why?
| | Ultraviolet Rays | 4 | 2022 | 384 | 0.300 |
Why?
| | Lung | 8 | 2024 | 3743 | 0.300 |
Why?
| | Apoptosis | 11 | 2024 | 2435 | 0.300 |
Why?
| | Intestinal Mucosa | 4 | 2024 | 575 | 0.300 |
Why?
| | Carbon Tetrachloride | 2 | 2025 | 13 | 0.300 |
Why?
| | Gene Expression Regulation | 10 | 2021 | 2505 | 0.300 |
Why?
| | Leptin | 2 | 2020 | 218 | 0.290 |
Why?
| | Hibernation | 2 | 2023 | 74 | 0.290 |
Why?
| | Skin Neoplasms | 3 | 2022 | 832 | 0.290 |
Why?
| | Aldehyde Dehydrogenase, Mitochondrial | 5 | 2020 | 24 | 0.280 |
Why?
| | Lipid Peroxidation | 5 | 2014 | 143 | 0.270 |
Why?
| | Kidney Diseases | 2 | 2023 | 367 | 0.270 |
Why?
| | Hepatic Stellate Cells | 2 | 2024 | 13 | 0.270 |
Why?
| | Genetic Vectors | 4 | 2010 | 311 | 0.270 |
Why?
| | RNA, Messenger | 12 | 2023 | 2675 | 0.270 |
Why?
| | Epithelial Cells | 7 | 2022 | 1032 | 0.270 |
Why?
| | Protein Processing, Post-Translational | 5 | 2024 | 449 | 0.270 |
Why?
| | Ileum | 3 | 2024 | 115 | 0.260 |
Why?
| | Triglycerides | 8 | 2021 | 523 | 0.260 |
Why?
| | Proto-Oncogene Proteins c-akt | 3 | 2019 | 421 | 0.260 |
Why?
| | Acute Kidney Injury | 2 | 2024 | 773 | 0.250 |
Why?
| | Lipid Droplets | 4 | 2019 | 22 | 0.250 |
Why?
| | Blister | 4 | 2014 | 40 | 0.250 |
Why?
| | Mice, Hairless | 9 | 2017 | 61 | 0.250 |
Why?
| | Irritants | 2 | 2017 | 43 | 0.250 |
Why?
| | HEK293 Cells | 5 | 2021 | 683 | 0.250 |
Why?
| | I-kappa B Proteins | 2 | 2022 | 73 | 0.250 |
Why?
| | Diet, Western | 3 | 2022 | 79 | 0.240 |
Why?
| | Aldehyde Oxidoreductases | 3 | 2010 | 29 | 0.240 |
Why?
| | Glycoproteins | 4 | 2021 | 337 | 0.240 |
Why?
| | Ascorbic Acid Deficiency | 1 | 2025 | 7 | 0.240 |
Why?
| | Proteomics | 6 | 2024 | 1009 | 0.240 |
Why?
| | Immunohistochemistry | 13 | 2018 | 1664 | 0.240 |
Why?
| | Carcinoma, Pancreatic Ductal | 2 | 2020 | 265 | 0.240 |
Why?
| | Transduction, Genetic | 3 | 2003 | 128 | 0.240 |
Why?
| | Scurvy | 1 | 2025 | 14 | 0.240 |
Why?
| | Wnt-5a Protein | 1 | 2024 | 21 | 0.240 |
Why?
| | Cell-Penetrating Peptides | 1 | 2025 | 19 | 0.240 |
Why?
| | Wnt3A Protein | 1 | 2024 | 10 | 0.240 |
Why?
| | Immunologic Surveillance | 1 | 2025 | 26 | 0.240 |
Why?
| | Endoplasmic Reticulum | 5 | 2019 | 260 | 0.230 |
Why?
| | Renal Insufficiency, Chronic | 2 | 2022 | 561 | 0.230 |
Why?
| | Gentamicins | 1 | 2025 | 52 | 0.230 |
Why?
| | AMP Deaminase | 1 | 2024 | 10 | 0.230 |
Why?
| | Gastrointestinal Microbiome | 3 | 2024 | 633 | 0.230 |
Why?
| | Pancreatic Neoplasms | 4 | 2020 | 875 | 0.230 |
Why?
| | Glycine | 2 | 2016 | 164 | 0.230 |
Why?
| | Gene Dosage | 1 | 2025 | 142 | 0.230 |
Why?
| | Ascorbic Acid | 1 | 2025 | 120 | 0.230 |
Why?
| | Tetrahydrofolate Dehydrogenase | 1 | 2024 | 22 | 0.230 |
Why?
| | Tetrahydrofolates | 1 | 2024 | 18 | 0.230 |
Why?
| | Tandem Mass Spectrometry | 7 | 2024 | 449 | 0.230 |
Why?
| | Salmonella Phages | 1 | 2024 | 3 | 0.230 |
Why?
| | Paraffin Embedding | 1 | 2024 | 27 | 0.230 |
Why?
| | Prophages | 1 | 2024 | 7 | 0.230 |
Why?
| | Intraepithelial Lymphocytes | 1 | 2024 | 14 | 0.230 |
Why?
| | Carcinogens | 3 | 2024 | 110 | 0.230 |
Why?
| | Cell Line | 14 | 2022 | 2731 | 0.220 |
Why?
| | Oxygen | 3 | 2018 | 899 | 0.220 |
Why?
| | Silymarin | 2 | 2016 | 198 | 0.220 |
Why?
| | Formaldehyde | 1 | 2024 | 57 | 0.220 |
Why?
| | Sphingosine | 1 | 2024 | 36 | 0.220 |
Why?
| | Dietary Sucrose | 2 | 2023 | 48 | 0.220 |
Why?
| | Gene Deletion | 4 | 2018 | 370 | 0.220 |
Why?
| | Lipopolysaccharides | 2 | 2024 | 856 | 0.220 |
Why?
| | Lysophospholipids | 1 | 2024 | 68 | 0.220 |
Why?
| | Animals, Newborn | 2 | 2024 | 803 | 0.220 |
Why?
| | Glycolipids | 2 | 2016 | 42 | 0.220 |
Why?
| | Lipoproteins | 2 | 2021 | 171 | 0.220 |
Why?
| | Transcription Factor AP-1 | 1 | 2024 | 85 | 0.220 |
Why?
| | NADPH Oxidases | 1 | 2024 | 107 | 0.220 |
Why?
| | Digestive System Diseases | 1 | 2023 | 25 | 0.220 |
Why?
| | Myeloid Differentiation Factor 88 | 1 | 2024 | 95 | 0.210 |
Why?
| | Endodeoxyribonucleases | 1 | 2024 | 67 | 0.210 |
Why?
| | Microtubule-Associated Proteins | 5 | 2019 | 190 | 0.210 |
Why?
| | Azotemia | 1 | 2023 | 7 | 0.210 |
Why?
| | Carcinoma, Squamous Cell | 3 | 2018 | 620 | 0.210 |
Why?
| | High Fructose Corn Syrup | 1 | 2023 | 8 | 0.210 |
Why?
| | Autophagy | 3 | 2022 | 265 | 0.210 |
Why?
| | Phagocytes | 1 | 2024 | 96 | 0.210 |
Why?
| | Estrogen Receptor beta | 1 | 2023 | 35 | 0.210 |
Why?
| | Patched-1 Receptor | 2 | 2022 | 15 | 0.210 |
Why?
| | Methionine | 1 | 2024 | 157 | 0.210 |
Why?
| | Urinary Tract Infections | 1 | 2025 | 145 | 0.210 |
Why?
| | Mitochondrial Proteins | 2 | 2015 | 244 | 0.210 |
Why?
| | Alprostadil | 4 | 1992 | 32 | 0.210 |
Why?
| | Oxidative Phosphorylation | 3 | 2021 | 184 | 0.210 |
Why?
| | Torpor | 1 | 2023 | 14 | 0.210 |
Why?
| | Corpus Luteum | 4 | 1992 | 20 | 0.210 |
Why?
| | Myeloid Cells | 1 | 2024 | 142 | 0.210 |
Why?
| | Herpesvirus 3, Human | 2 | 2021 | 330 | 0.210 |
Why?
| | Antidotes | 2 | 2015 | 135 | 0.200 |
Why?
| | Pseudomonas Infections | 1 | 2025 | 213 | 0.200 |
Why?
| | Catalase | 3 | 2017 | 122 | 0.200 |
Why?
| | Cell Membrane | 5 | 2016 | 720 | 0.200 |
Why?
| | Phospholipids | 2 | 2017 | 207 | 0.200 |
Why?
| | Alcoholism | 2 | 2022 | 766 | 0.200 |
Why?
| | Proteins | 6 | 2013 | 932 | 0.200 |
Why?
| | Dermatitis, Contact | 2 | 2013 | 19 | 0.200 |
Why?
| | Membrane Glycoproteins | 4 | 2021 | 466 | 0.200 |
Why?
| | Nucleotides | 2 | 2021 | 117 | 0.200 |
Why?
| | Immune Tolerance | 1 | 2025 | 349 | 0.200 |
Why?
| | Weight Gain | 4 | 2019 | 503 | 0.200 |
Why?
| | Receptors, Antigen, T-Cell, alpha-beta | 1 | 2024 | 334 | 0.200 |
Why?
| | Cell Proliferation | 11 | 2020 | 2344 | 0.200 |
Why?
| | Estrogen Receptor alpha | 1 | 2023 | 132 | 0.200 |
Why?
| | Phosphorylation | 6 | 2020 | 1681 | 0.190 |
Why?
| | Abdominal Injuries | 1 | 2023 | 117 | 0.190 |
Why?
| | Receptors, Androgen | 1 | 2023 | 143 | 0.190 |
Why?
| | Pneumonia, Pneumococcal | 1 | 2022 | 40 | 0.190 |
Why?
| | Thermogenesis | 2 | 2019 | 44 | 0.190 |
Why?
| | Drug Delivery Systems | 1 | 2025 | 325 | 0.190 |
Why?
| | Hepatitis, Alcoholic | 1 | 2021 | 13 | 0.190 |
Why?
| | Blotting, Western | 9 | 2015 | 1164 | 0.190 |
Why?
| | Energy Intake | 3 | 2021 | 454 | 0.190 |
Why?
| | Isoxazoles | 1 | 2021 | 54 | 0.190 |
Why?
| | CD8-Positive T-Lymphocytes | 2 | 2025 | 846 | 0.190 |
Why?
| | Viral Proteins | 1 | 2024 | 321 | 0.190 |
Why?
| | Bacterial Toxins | 1 | 2022 | 106 | 0.190 |
Why?
| | Phytosterols | 1 | 2021 | 12 | 0.190 |
Why?
| | Cell Culture Techniques | 2 | 2018 | 345 | 0.190 |
Why?
| | Colonic Neoplasms | 3 | 2011 | 242 | 0.190 |
Why?
| | Estrogens | 2 | 2023 | 342 | 0.190 |
Why?
| | Neutrophils | 2 | 2024 | 1193 | 0.180 |
Why?
| | Adipose Tissue, Brown | 2 | 2019 | 51 | 0.180 |
Why?
| | Phenylurea Compounds | 1 | 2022 | 89 | 0.180 |
Why?
| | Drug Resistance | 1 | 2022 | 163 | 0.180 |
Why?
| | Glucose | 4 | 2023 | 982 | 0.180 |
Why?
| | Adrenal Glands | 1 | 2021 | 70 | 0.180 |
Why?
| | NF-E2-Related Factor 2 | 2 | 2019 | 67 | 0.180 |
Why?
| | Eye | 1 | 2022 | 103 | 0.180 |
Why?
| | Peroxiredoxins | 2 | 2018 | 24 | 0.180 |
Why?
| | Fatty Acids | 4 | 2022 | 415 | 0.180 |
Why?
| | Receptors, Vasopressin | 1 | 2021 | 19 | 0.180 |
Why?
| | Pneumococcal Infections | 1 | 2022 | 110 | 0.180 |
Why?
| | Hepatitis | 2 | 2019 | 47 | 0.180 |
Why?
| | Janus Kinase 1 | 1 | 2020 | 24 | 0.180 |
Why?
| | 3T3 Cells | 4 | 2003 | 151 | 0.180 |
Why?
| | Janus Kinase 2 | 1 | 2020 | 32 | 0.180 |
Why?
| | Mucoproteins | 1 | 2020 | 10 | 0.180 |
Why?
| | Programmed Cell Death 1 Receptor | 1 | 2022 | 228 | 0.180 |
Why?
| | Quinolines | 1 | 2022 | 153 | 0.180 |
Why?
| | Biomarkers, Tumor | 3 | 2016 | 1181 | 0.180 |
Why?
| | Azetidines | 1 | 2020 | 40 | 0.180 |
Why?
| | Sterol Regulatory Element Binding Protein 1 | 3 | 2016 | 57 | 0.180 |
Why?
| | Momordica charantia | 1 | 2020 | 15 | 0.170 |
Why?
| | Adenomatous Polyposis Coli | 1 | 2020 | 33 | 0.170 |
Why?
| | Vasopressins | 1 | 2021 | 62 | 0.170 |
Why?
| | Kidney Tubules | 2 | 2019 | 114 | 0.170 |
Why?
| | Positive Regulatory Domain I-Binding Factor 1 | 1 | 2020 | 18 | 0.170 |
Why?
| | Case-Control Studies | 5 | 2020 | 3328 | 0.170 |
Why?
| | Biomarkers | 7 | 2023 | 3880 | 0.170 |
Why?
| | Uric Acid | 1 | 2021 | 160 | 0.170 |
Why?
| | Cell Transformation, Neoplastic | 2 | 2016 | 325 | 0.170 |
Why?
| | Herpesviridae Infections | 1 | 2021 | 134 | 0.170 |
Why?
| | Lipoproteins, LDL | 1 | 2020 | 126 | 0.170 |
Why?
| | Receptors, G-Protein-Coupled | 2 | 2022 | 203 | 0.170 |
Why?
| | Sugars | 1 | 2020 | 37 | 0.170 |
Why?
| | Monocytes | 2 | 2021 | 542 | 0.170 |
Why?
| | Lysine | 2 | 2024 | 278 | 0.170 |
Why?
| | Gene Expression | 2 | 2023 | 1456 | 0.170 |
Why?
| | Myometrium | 1 | 2020 | 35 | 0.170 |
Why?
| | Protein Biosynthesis | 3 | 2001 | 397 | 0.170 |
Why?
| | Melanocytes | 1 | 2020 | 69 | 0.170 |
Why?
| | Lymphatic Vessels | 1 | 2020 | 60 | 0.170 |
Why?
| | PPAR alpha | 3 | 2016 | 59 | 0.170 |
Why?
| | Middle Aged | 11 | 2024 | 30889 | 0.160 |
Why?
| | Up-Regulation | 6 | 2022 | 825 | 0.160 |
Why?
| | Sucrose | 3 | 2018 | 94 | 0.160 |
Why?
| | Adipose Tissue | 3 | 2019 | 589 | 0.160 |
Why?
| | Intestines | 3 | 2020 | 344 | 0.160 |
Why?
| | SNARE Proteins | 1 | 2019 | 39 | 0.160 |
Why?
| | Cholesterol | 5 | 2022 | 406 | 0.160 |
Why?
| | Electron Microscope Tomography | 1 | 2019 | 39 | 0.160 |
Why?
| | Gastrointestinal Motility | 1 | 2019 | 26 | 0.160 |
Why?
| | Cell Adhesion Molecules | 1 | 2020 | 172 | 0.160 |
Why?
| | Deoxycytidine | 1 | 2020 | 163 | 0.160 |
Why?
| | Cholesterol, Dietary | 1 | 2019 | 18 | 0.160 |
Why?
| | Gene Expression Regulation, Developmental | 2 | 2020 | 817 | 0.160 |
Why?
| | Body Weight Maintenance | 1 | 2019 | 16 | 0.160 |
Why?
| | Vascular Endothelial Growth Factor A | 1 | 2022 | 500 | 0.160 |
Why?
| | Cytokines | 5 | 2022 | 1983 | 0.160 |
Why?
| | Acylation | 1 | 2019 | 28 | 0.160 |
Why?
| | Gene Expression Regulation, Neoplastic | 3 | 2020 | 1351 | 0.160 |
Why?
| | Tumor Suppressor Protein p53 | 3 | 2020 | 508 | 0.160 |
Why?
| | Bone Morphogenetic Protein 2 | 1 | 2019 | 62 | 0.160 |
Why?
| | Kupffer Cells | 1 | 2019 | 49 | 0.160 |
Why?
| | Leishmania major | 1 | 2018 | 7 | 0.160 |
Why?
| | Altitude Sickness | 1 | 2020 | 137 | 0.150 |
Why?
| | Models, Animal | 2 | 2022 | 366 | 0.150 |
Why?
| | Leishmaniasis, Cutaneous | 1 | 2018 | 9 | 0.150 |
Why?
| | Emphysema | 1 | 2019 | 94 | 0.150 |
Why?
| | Chromatography, Liquid | 5 | 2024 | 374 | 0.150 |
Why?
| | Hypothalamo-Hypophyseal System | 1 | 2020 | 177 | 0.150 |
Why?
| | Antineoplastic Agents, Phytogenic | 2 | 2019 | 185 | 0.150 |
Why?
| | Plant Extracts | 1 | 2020 | 179 | 0.150 |
Why?
| | Thioredoxin-Disulfide Reductase | 1 | 2018 | 13 | 0.150 |
Why?
| | Nitric Oxide | 3 | 2020 | 882 | 0.150 |
Why?
| | Arteries | 1 | 2020 | 262 | 0.150 |
Why?
| | Carbohydrate Metabolism | 1 | 2018 | 60 | 0.150 |
Why?
| | Adipose Tissue, White | 1 | 2018 | 37 | 0.150 |
Why?
| | Intestine, Small | 2 | 2020 | 143 | 0.150 |
Why?
| | Bile Ducts | 1 | 2018 | 67 | 0.150 |
Why?
| | Protein Kinases | 1 | 2020 | 309 | 0.150 |
Why?
| | Adenocarcinoma | 3 | 2011 | 888 | 0.150 |
Why?
| | Thyroid Neoplasms | 1 | 2022 | 309 | 0.150 |
Why?
| | Hep G2 Cells | 4 | 2021 | 61 | 0.150 |
Why?
| | Nanoparticles | 1 | 2022 | 368 | 0.150 |
Why?
| | Cold Temperature | 1 | 2019 | 153 | 0.140 |
Why?
| | Gene Knockout Techniques | 1 | 2018 | 109 | 0.140 |
Why?
| | Phenotype | 3 | 2023 | 3044 | 0.140 |
Why?
| | Sodium Chloride, Dietary | 1 | 2018 | 36 | 0.140 |
Why?
| | Desoxycorticosterone Acetate | 1 | 2017 | 4 | 0.140 |
Why?
| | Metabolomics | 5 | 2024 | 599 | 0.140 |
Why?
| | Glucosides | 1 | 2018 | 38 | 0.140 |
Why?
| | Amino Acid Sequence | 7 | 2020 | 2040 | 0.140 |
Why?
| | Base Sequence | 6 | 2015 | 2135 | 0.140 |
Why?
| | Relaxin | 1 | 2017 | 18 | 0.140 |
Why?
| | Diabetes Mellitus, Type 2 | 3 | 2022 | 2429 | 0.140 |
Why?
| | Pneumonia | 1 | 2023 | 598 | 0.140 |
Why?
| | Anti-Bacterial Agents | 2 | 2025 | 1663 | 0.140 |
Why?
| | Insulin Resistance | 4 | 2019 | 1164 | 0.140 |
Why?
| | Acetyl-CoA Carboxylase | 2 | 2014 | 33 | 0.140 |
Why?
| | Hypersensitivity | 1 | 2020 | 249 | 0.140 |
Why?
| | Zebrafish Proteins | 1 | 2020 | 269 | 0.140 |
Why?
| | Benzhydryl Compounds | 1 | 2018 | 66 | 0.140 |
Why?
| | Phosphatidylethanolamine N-Methyltransferase | 1 | 2017 | 8 | 0.140 |
Why?
| | Virulence Factors | 1 | 2018 | 152 | 0.140 |
Why?
| | Phosgene | 1 | 2017 | 6 | 0.140 |
Why?
| | Cytochrome d Group | 1 | 2016 | 2 | 0.140 |
Why?
| | Oximes | 1 | 2017 | 20 | 0.140 |
Why?
| | Drug-Related Side Effects and Adverse Reactions | 1 | 2019 | 253 | 0.140 |
Why?
| | Cytochrome b Group | 1 | 2016 | 19 | 0.140 |
Why?
| | Metabolic Diseases | 1 | 2018 | 105 | 0.140 |
Why?
| | Reactive Oxygen Species | 3 | 2022 | 577 | 0.140 |
Why?
| | Vasodilation | 1 | 2020 | 464 | 0.140 |
Why?
| | DNA Primers | 5 | 2015 | 510 | 0.130 |
Why?
| | Transcription, Genetic | 3 | 2005 | 1404 | 0.130 |
Why?
| | Sulfonamides | 1 | 2020 | 499 | 0.130 |
Why?
| | Sciuridae | 2 | 2023 | 145 | 0.130 |
Why?
| | Mitochondria, Muscle | 1 | 2018 | 110 | 0.130 |
Why?
| | Nephrosclerosis | 1 | 2016 | 6 | 0.130 |
Why?
| | Proteome | 2 | 2019 | 430 | 0.130 |
Why?
| | Apocrine Glands | 1 | 2016 | 4 | 0.130 |
Why?
| | Temperature | 2 | 2018 | 625 | 0.130 |
Why?
| | Spleen | 2 | 2018 | 507 | 0.130 |
Why?
| | Xanthine Dehydrogenase | 1 | 2016 | 24 | 0.130 |
Why?
| | Biliary Atresia | 1 | 2018 | 160 | 0.130 |
Why?
| | Cells, Cultured | 10 | 2020 | 4001 | 0.130 |
Why?
| | Necrosis | 2 | 2015 | 229 | 0.130 |
Why?
| | Glycolysis | 3 | 2024 | 293 | 0.130 |
Why?
| | Chemical and Drug Induced Liver Injury, Chronic | 1 | 2016 | 11 | 0.130 |
Why?
| | Disease Progression | 6 | 2020 | 2602 | 0.130 |
Why?
| | Cell Differentiation | 7 | 2020 | 1900 | 0.130 |
Why?
| | Metalloporphyrins | 2 | 2014 | 101 | 0.130 |
Why?
| | Fatty Acids, Omega-6 | 1 | 2016 | 47 | 0.130 |
Why?
| | Mice, Obese | 3 | 2023 | 57 | 0.130 |
Why?
| | Heart Defects, Congenital | 1 | 2023 | 740 | 0.130 |
Why?
| | End Stage Liver Disease | 1 | 2017 | 77 | 0.130 |
Why?
| | Maternal Nutritional Physiological Phenomena | 1 | 2018 | 169 | 0.130 |
Why?
| | Molecular Sequence Data | 7 | 2015 | 2819 | 0.130 |
Why?
| | Rabbits | 10 | 2002 | 758 | 0.130 |
Why?
| | Optical Imaging | 1 | 2016 | 56 | 0.130 |
Why?
| | Disease Susceptibility | 2 | 2020 | 331 | 0.130 |
Why?
| | Chromosomes, Human, Pair 1 | 1 | 1996 | 70 | 0.130 |
Why?
| | Acetylcysteine | 2 | 2022 | 140 | 0.130 |
Why?
| | Choline | 1 | 2017 | 119 | 0.130 |
Why?
| | Estradiol | 4 | 1988 | 486 | 0.130 |
Why?
| | Zebrafish | 1 | 2020 | 464 | 0.130 |
Why?
| | Liver Cirrhosis, Alcoholic | 1 | 2015 | 17 | 0.130 |
Why?
| | Recombinant Proteins | 3 | 2017 | 1281 | 0.130 |
Why?
| | Epithelium, Corneal | 1 | 2016 | 36 | 0.130 |
Why?
| | Protein Structure, Tertiary | 3 | 2011 | 835 | 0.120 |
Why?
| | Lung Neoplasms | 3 | 2018 | 2328 | 0.120 |
Why?
| | Severity of Illness Index | 2 | 2020 | 2721 | 0.120 |
Why?
| | Drug Resistance, Neoplasm | 1 | 2020 | 749 | 0.120 |
Why?
| | Microbiota | 1 | 2023 | 719 | 0.120 |
Why?
| | Cell Division | 7 | 1988 | 778 | 0.120 |
Why?
| | Fibrosis | 4 | 2022 | 512 | 0.120 |
Why?
| | Peroxidase | 5 | 2015 | 169 | 0.120 |
Why?
| | Epidermis | 2 | 2014 | 156 | 0.120 |
Why?
| | Down-Regulation | 4 | 2022 | 631 | 0.120 |
Why?
| | Chemokines | 3 | 2023 | 221 | 0.120 |
Why?
| | Pelvis | 1 | 2016 | 101 | 0.120 |
Why?
| | Mice, Transgenic | 5 | 2021 | 2071 | 0.120 |
Why?
| | Fatty Acids, Omega-3 | 1 | 2016 | 137 | 0.120 |
Why?
| | Space Flight | 1 | 2016 | 122 | 0.120 |
Why?
| | Hematopoietic System | 1 | 2014 | 7 | 0.120 |
Why?
| | Skin Diseases | 1 | 2017 | 141 | 0.120 |
Why?
| | MicroRNAs | 1 | 2021 | 677 | 0.120 |
Why?
| | Carcinogenesis | 3 | 2023 | 209 | 0.120 |
Why?
| | Cytoprotection | 2 | 2015 | 50 | 0.120 |
Why?
| | Microscopy, Fluorescence | 1 | 2016 | 399 | 0.120 |
Why?
| | Interleukin-6 | 3 | 2023 | 716 | 0.120 |
Why?
| | Acetylation | 3 | 2024 | 237 | 0.120 |
Why?
| | Aged | 7 | 2024 | 21953 | 0.120 |
Why?
| | Diet | 3 | 2018 | 1199 | 0.120 |
Why?
| | Protein Kinase Inhibitors | 1 | 2020 | 872 | 0.120 |
Why?
| | Alanine Transaminase | 4 | 2016 | 150 | 0.110 |
Why?
| | Fetal Growth Retardation | 1 | 2020 | 543 | 0.110 |
Why?
| | Homocysteine | 3 | 2024 | 149 | 0.110 |
Why?
| | Mice, Inbred ICR | 3 | 2021 | 107 | 0.110 |
Why?
| | Body Weight | 5 | 2016 | 928 | 0.110 |
Why?
| | Motor Activity | 1 | 2019 | 668 | 0.110 |
Why?
| | Breast Feeding | 1 | 2018 | 422 | 0.110 |
Why?
| | Vagina | 1 | 2016 | 175 | 0.110 |
Why?
| | Adult | 10 | 2024 | 35299 | 0.110 |
Why?
| | Hyperkeratosis, Epidermolytic | 1 | 2014 | 21 | 0.110 |
Why?
| | 4-Nitroquinoline-1-oxide | 1 | 2013 | 8 | 0.110 |
Why?
| | Dermis | 1 | 2014 | 31 | 0.110 |
Why?
| | Metabolism, Inborn Errors | 1 | 2014 | 40 | 0.110 |
Why?
| | Cloning, Molecular | 4 | 2010 | 522 | 0.110 |
Why?
| | Weight Loss | 1 | 2019 | 725 | 0.110 |
Why?
| | Stilbenes | 1 | 2013 | 36 | 0.110 |
Why?
| | Tongue Neoplasms | 1 | 2013 | 23 | 0.110 |
Why?
| | Methylation | 1 | 2014 | 227 | 0.110 |
Why?
| | Prediabetic State | 1 | 2016 | 245 | 0.110 |
Why?
| | Heart | 1 | 2017 | 635 | 0.110 |
Why?
| | Macrophage Activation | 3 | 2023 | 187 | 0.110 |
Why?
| | Kidney Tubules, Proximal | 1 | 2014 | 125 | 0.110 |
Why?
| | Grape Seed Extract | 1 | 2013 | 44 | 0.110 |
Why?
| | Feces | 3 | 2024 | 435 | 0.110 |
Why?
| | Tetradecanoylphorbol Acetate | 2 | 1996 | 150 | 0.100 |
Why?
| | Phosphoproteins | 2 | 2013 | 327 | 0.100 |
Why?
| | Isoproterenol | 1 | 2013 | 107 | 0.100 |
Why?
| | Organ Size | 4 | 2016 | 440 | 0.100 |
Why?
| | Colorectal Neoplasms | 1 | 2020 | 746 | 0.100 |
Why?
| | Anticarcinogenic Agents | 1 | 2013 | 77 | 0.100 |
Why?
| | Melanoma | 1 | 2020 | 752 | 0.100 |
Why?
| | Protein Structure, Secondary | 3 | 2018 | 338 | 0.100 |
Why?
| | Proteasome Endopeptidase Complex | 2 | 2016 | 145 | 0.100 |
Why?
| | Anti-Inflammatory Agents | 1 | 2016 | 468 | 0.100 |
Why?
| | Inositol Phosphates | 3 | 1988 | 22 | 0.100 |
Why?
| | B-Lymphocytes | 1 | 2018 | 817 | 0.100 |
Why?
| | Green Fluorescent Proteins | 3 | 2011 | 380 | 0.100 |
Why?
| | Lymphopenia | 1 | 2013 | 59 | 0.100 |
Why?
| | Fatty Acid-Binding Proteins | 1 | 2013 | 67 | 0.100 |
Why?
| | Microfilament Proteins | 1 | 2013 | 125 | 0.100 |
Why?
| | Coxsackie and Adenovirus Receptor-Like Membrane Protein | 2 | 2003 | 7 | 0.100 |
Why?
| | Natural Killer T-Cells | 1 | 2013 | 65 | 0.100 |
Why?
| | Testis | 1 | 1992 | 144 | 0.100 |
Why?
| | Myocardium | 1 | 2017 | 965 | 0.100 |
Why?
| | Mothers | 2 | 2018 | 729 | 0.100 |
Why?
| | Carrier Proteins | 3 | 2017 | 732 | 0.100 |
Why?
| | Cattle | 6 | 2016 | 960 | 0.100 |
Why?
| | Perilipin-3 | 2 | 2008 | 2 | 0.090 |
Why?
| | Mammals | 2 | 2023 | 268 | 0.090 |
Why?
| | DNA, Complementary | 3 | 2016 | 267 | 0.090 |
Why?
| | Arousal | 1 | 2012 | 150 | 0.090 |
Why?
| | Reactive Nitrogen Species | 1 | 2011 | 22 | 0.090 |
Why?
| | Taurine | 1 | 2011 | 40 | 0.090 |
Why?
| | Eye Proteins | 2 | 2021 | 88 | 0.090 |
Why?
| | Administration, Cutaneous | 3 | 2017 | 122 | 0.090 |
Why?
| | Ligands | 2 | 2023 | 614 | 0.090 |
Why?
| | Olfactory Mucosa | 1 | 2011 | 64 | 0.090 |
Why?
| | beta Catenin | 2 | 2024 | 219 | 0.090 |
Why?
| | Nasal Cavity | 1 | 2011 | 50 | 0.090 |
Why?
| | Neurons | 1 | 2019 | 1448 | 0.090 |
Why?
| | Microtubules | 1 | 2013 | 259 | 0.090 |
Why?
| | Mutation | 3 | 2020 | 3689 | 0.090 |
Why?
| | Acetaldehyde | 1 | 2010 | 17 | 0.090 |
Why?
| | Blood Proteins | 1 | 2012 | 239 | 0.090 |
Why?
| | Cohort Studies | 1 | 2020 | 5388 | 0.090 |
Why?
| | Chenodeoxycholic Acid | 2 | 2021 | 14 | 0.080 |
Why?
| | Luminescent Proteins | 2 | 2001 | 174 | 0.080 |
Why?
| | Heme Oxygenase-1 | 2 | 2021 | 59 | 0.080 |
Why?
| | Reverse Transcriptase Polymerase Chain Reaction | 4 | 2015 | 940 | 0.080 |
Why?
| | Multidrug Resistance-Associated Proteins | 2 | 2021 | 36 | 0.080 |
Why?
| | Mice, Inbred BALB C | 3 | 2018 | 1228 | 0.080 |
Why?
| | Betaine | 2 | 2024 | 72 | 0.080 |
Why?
| | Casein Kinase II | 1 | 2009 | 21 | 0.080 |
Why?
| | COS Cells | 2 | 2003 | 184 | 0.080 |
Why?
| | Immediate-Early Proteins | 1 | 2009 | 51 | 0.080 |
Why?
| | Recombinant Fusion Proteins | 2 | 2011 | 634 | 0.080 |
Why?
| | Protein Folding | 1 | 2011 | 265 | 0.080 |
Why?
| | Peroxiredoxin VI | 1 | 2009 | 5 | 0.080 |
Why?
| | Hyaluronan Receptors | 1 | 2009 | 97 | 0.080 |
Why?
| | Rats, Sprague-Dawley | 4 | 2016 | 2239 | 0.080 |
Why?
| | Pregnancy | 6 | 2020 | 6357 | 0.080 |
Why?
| | Lysosomes | 2 | 2019 | 135 | 0.080 |
Why?
| | Viral Envelope Proteins | 1 | 2009 | 80 | 0.080 |
Why?
| | Biomarkers, Pharmacological | 1 | 2008 | 26 | 0.080 |
Why?
| | Serine | 1 | 2009 | 135 | 0.080 |
Why?
| | Neoplasm Invasiveness | 3 | 2020 | 480 | 0.080 |
Why?
| | Metabolome | 2 | 2024 | 319 | 0.080 |
Why?
| | Cysteine Proteinase Inhibitors | 2 | 2014 | 48 | 0.080 |
Why?
| | Organ Specificity | 3 | 2018 | 291 | 0.080 |
Why?
| | Prospective Studies | 1 | 2020 | 7036 | 0.080 |
Why?
| | Exosomes | 1 | 2009 | 96 | 0.080 |
Why?
| | Oleic Acid | 1 | 2008 | 39 | 0.080 |
Why?
| | Hypertension | 1 | 2017 | 1235 | 0.070 |
Why?
| | Mutant Proteins | 1 | 2008 | 98 | 0.070 |
Why?
| | Structure-Activity Relationship | 2 | 2008 | 530 | 0.070 |
Why?
| | Endoplasmic Reticulum Stress | 2 | 2019 | 101 | 0.070 |
Why?
| | Kidney Function Tests | 2 | 2019 | 145 | 0.070 |
Why?
| | Tissue Distribution | 3 | 2007 | 291 | 0.070 |
Why?
| | Tumor Suppressor Proteins | 2 | 2020 | 313 | 0.070 |
Why?
| | Adiposity | 2 | 2015 | 504 | 0.070 |
Why?
| | Vasotocin | 1 | 2006 | 5 | 0.070 |
Why?
| | Affinity Labels | 3 | 1992 | 25 | 0.070 |
Why?
| | CCAAT-Enhancer-Binding Protein-beta | 1 | 2007 | 31 | 0.070 |
Why?
| | Muscle, Smooth | 2 | 2019 | 145 | 0.070 |
Why?
| | Urethane | 1 | 2007 | 41 | 0.070 |
Why?
| | Muscle Tonus | 1 | 2006 | 19 | 0.070 |
Why?
| | Lipogenesis | 2 | 2018 | 59 | 0.070 |
Why?
| | Uterine Contraction | 1 | 2006 | 17 | 0.070 |
Why?
| | Tumor Cells, Cultured | 3 | 2020 | 930 | 0.070 |
Why?
| | Prostaglandins | 1 | 2006 | 84 | 0.070 |
Why?
| | Sugar Phosphates | 1 | 1986 | 2 | 0.070 |
Why?
| | Lizards | 1 | 2006 | 34 | 0.070 |
Why?
| | Azides | 3 | 1992 | 46 | 0.070 |
Why?
| | Risk Factors | 1 | 2020 | 9704 | 0.070 |
Why?
| | Nitric Oxide Synthase Type II | 3 | 2014 | 167 | 0.070 |
Why?
| | Mice, Nude | 2 | 2020 | 682 | 0.070 |
Why?
| | Thermodynamics | 1 | 2008 | 405 | 0.060 |
Why?
| | Amidinotransferases | 2 | 2016 | 2 | 0.060 |
Why?
| | Guanidinoacetate N-Methyltransferase | 2 | 2016 | 5 | 0.060 |
Why?
| | S-Adenosylhomocysteine | 2 | 2016 | 21 | 0.060 |
Why?
| | Kidney Glomerulus | 2 | 2018 | 107 | 0.060 |
Why?
| | L-Gulonolactone Oxidase | 1 | 2025 | 1 | 0.060 |
Why?
| | CCAAT-Enhancer-Binding Protein-alpha | 1 | 2005 | 14 | 0.060 |
Why?
| | Bone Marrow | 1 | 2007 | 267 | 0.060 |
Why?
| | S-Adenosylmethionine | 2 | 2016 | 52 | 0.060 |
Why?
| | Metabolic Networks and Pathways | 2 | 2019 | 175 | 0.060 |
Why?
| | Sequence Analysis, RNA | 2 | 2018 | 429 | 0.060 |
Why?
| | Diethylnitrosamine | 1 | 2025 | 7 | 0.060 |
Why?
| | DNA Replication | 1 | 1987 | 225 | 0.060 |
Why?
| | Perilipin-1 | 2 | 2019 | 16 | 0.060 |
Why?
| | Transforming Growth Factor beta | 2 | 2020 | 445 | 0.060 |
Why?
| | Chronic Disease | 1 | 2011 | 1705 | 0.060 |
Why?
| | Ovarian Neoplasms | 1 | 2010 | 488 | 0.060 |
Why?
| | Bacteroidetes | 1 | 2024 | 23 | 0.060 |
Why?
| | Cell Transdifferentiation | 1 | 2024 | 30 | 0.060 |
Why?
| | Adenoma | 1 | 2007 | 213 | 0.060 |
Why?
| | Liver Regeneration | 1 | 2024 | 40 | 0.060 |
Why?
| | Fructosephosphates | 1 | 2024 | 1 | 0.060 |
Why?
| | Diabetes Mellitus | 2 | 2018 | 999 | 0.060 |
Why?
| | Transcription Factors | 3 | 2019 | 1628 | 0.060 |
Why?
| | Edema | 2 | 2017 | 125 | 0.060 |
Why?
| | Fecal Microbiota Transplantation | 1 | 2024 | 18 | 0.060 |
Why?
| | Ileitis | 1 | 2024 | 32 | 0.060 |
Why?
| | Tissue Fixation | 1 | 2024 | 33 | 0.060 |
Why?
| | Macrophage Activation Syndrome | 1 | 2024 | 21 | 0.060 |
Why?
| | Tamoxifen | 2 | 2020 | 200 | 0.060 |
Why?
| | Oxygen Consumption | 2 | 2018 | 669 | 0.060 |
Why?
| | Polymerase Chain Reaction | 2 | 1998 | 1020 | 0.060 |
Why?
| | Rats, Wistar | 2 | 2016 | 397 | 0.060 |
Why?
| | Cyclic GMP | 2 | 2019 | 85 | 0.060 |
Why?
| | Diet, Fat-Restricted | 2 | 2015 | 79 | 0.060 |
Why?
| | Fingolimod Hydrochloride | 1 | 2024 | 36 | 0.060 |
Why?
| | Poly Adenosine Diphosphate Ribose | 1 | 2023 | 2 | 0.060 |
Why?
| | Cystathionine beta-Synthase | 1 | 2024 | 68 | 0.060 |
Why?
| | Anaerobiosis | 1 | 2024 | 57 | 0.060 |
Why?
| | Proto-Oncogene Proteins c-jun | 1 | 2024 | 52 | 0.060 |
Why?
| | Cyclooxygenase 2 | 2 | 2015 | 172 | 0.050 |
Why?
| | Glycoside Hydrolases | 1 | 2023 | 33 | 0.050 |
Why?
| | Genes, Regulator | 1 | 2023 | 33 | 0.050 |
Why?
| | Macrophages, Alveolar | 1 | 2007 | 376 | 0.050 |
Why?
| | ARNTL Transcription Factors | 1 | 2023 | 16 | 0.050 |
Why?
| | Transcription Factor RelA | 1 | 2024 | 79 | 0.050 |
Why?
| | Time Factors | 5 | 2015 | 6482 | 0.050 |
Why?
| | Gene Expression Profiling | 3 | 2017 | 1688 | 0.050 |
Why?
| | Mammary Glands, Human | 2 | 2016 | 64 | 0.050 |
Why?
| | Acute-Phase Reaction | 1 | 2023 | 40 | 0.050 |
Why?
| | Furosemide | 1 | 2023 | 38 | 0.050 |
Why?
| | Intercellular Signaling Peptides and Proteins | 1 | 2005 | 371 | 0.050 |
Why?
| | NF-kappa B p50 Subunit | 1 | 2023 | 21 | 0.050 |
Why?
| | Receptors, Interferon | 1 | 2023 | 50 | 0.050 |
Why?
| | Wnt Signaling Pathway | 1 | 2024 | 165 | 0.050 |
Why?
| | Lipocalin-2 | 1 | 2023 | 76 | 0.050 |
Why?
| | RNA, Transfer | 1 | 2024 | 130 | 0.050 |
Why?
| | Respiration | 1 | 2024 | 190 | 0.050 |
Why?
| | Urinary Bladder Neoplasms | 2 | 2005 | 226 | 0.050 |
Why?
| | Folic Acid | 1 | 2024 | 184 | 0.050 |
Why?
| | Carbon | 1 | 2024 | 207 | 0.050 |
Why?
| | Interleukin-18 | 1 | 2024 | 236 | 0.050 |
Why?
| | Cell Survival | 4 | 2014 | 1077 | 0.050 |
Why?
| | Sequence Deletion | 1 | 2003 | 178 | 0.050 |
Why?
| | Salmonella typhimurium | 1 | 2024 | 176 | 0.050 |
Why?
| | Chemokine CCL7 | 1 | 2022 | 2 | 0.050 |
Why?
| | Buthionine Sulfoximine | 1 | 2022 | 8 | 0.050 |
Why?
| | Antigens, CD | 2 | 2005 | 482 | 0.050 |
Why?
| | Pseudomonas aeruginosa | 1 | 2025 | 336 | 0.050 |
Why?
| | Inhibitor of Apoptosis Proteins | 4 | 2003 | 45 | 0.050 |
Why?
| | 8-Bromo Cyclic Adenosine Monophosphate | 2 | 1996 | 20 | 0.050 |
Why?
| | Hydrophobic and Hydrophilic Interactions | 1 | 2003 | 184 | 0.050 |
Why?
| | Fluorine | 2 | 1992 | 15 | 0.050 |
Why?
| | Rats, Inbred F344 | 2 | 1992 | 251 | 0.050 |
Why?
| | Cervix Uteri | 1 | 2002 | 50 | 0.050 |
Why?
| | Adenovirus E1A Proteins | 1 | 2001 | 11 | 0.050 |
Why?
| | Sterols | 1 | 2021 | 18 | 0.050 |
Why?
| | Benzimidazoles | 1 | 2023 | 157 | 0.050 |
Why?
| | Nuclear Receptor Co-Repressor 1 | 1 | 2021 | 16 | 0.050 |
Why?
| | Sequence Homology, Amino Acid | 2 | 2007 | 367 | 0.050 |
Why?
| | Dose-Response Relationship, Drug | 3 | 2015 | 1936 | 0.050 |
Why?
| | Adenoviruses, Human | 1 | 2001 | 26 | 0.050 |
Why?
| | Immune Sera | 2 | 1992 | 86 | 0.050 |
Why?
| | Dysbiosis | 1 | 2023 | 166 | 0.050 |
Why?
| | Systems Analysis | 1 | 2021 | 21 | 0.050 |
Why?
| | Sodium Glutamate | 1 | 2021 | 9 | 0.050 |
Why?
| | Carcinoma, Transitional Cell | 1 | 2002 | 60 | 0.050 |
Why?
| | Homeostasis | 2 | 2016 | 603 | 0.050 |
Why?
| | Interferons | 1 | 2023 | 192 | 0.050 |
Why?
| | PAX6 Transcription Factor | 1 | 2021 | 19 | 0.050 |
Why?
| | Intestinal Diseases | 1 | 2021 | 35 | 0.050 |
Why?
| | Receptors, Tumor Necrosis Factor, Type I | 1 | 2021 | 83 | 0.050 |
Why?
| | Dilatation | 1 | 2022 | 59 | 0.050 |
Why?
| | NLR Family, Pyrin Domain-Containing 3 Protein | 1 | 2023 | 153 | 0.050 |
Why?
| | Macaca fascicularis | 1 | 2021 | 48 | 0.050 |
Why?
| | Bilirubin | 1 | 2021 | 92 | 0.050 |
Why?
| | Chromosomal Proteins, Non-Histone | 1 | 2002 | 115 | 0.050 |
Why?
| | Infliximab | 1 | 2021 | 100 | 0.050 |
Why?
| | Gene Expression Regulation, Viral | 1 | 2001 | 84 | 0.050 |
Why?
| | Heme | 1 | 2021 | 76 | 0.050 |
Why?
| | Gas Chromatography-Mass Spectrometry | 1 | 2021 | 126 | 0.050 |
Why?
| | Cation Exchange Resins | 1 | 2001 | 7 | 0.050 |
Why?
| | Histological Techniques | 1 | 2021 | 39 | 0.050 |
Why?
| | Chromatin Immunoprecipitation | 1 | 2021 | 131 | 0.050 |
Why?
| | Silicon Dioxide | 1 | 2022 | 111 | 0.050 |
Why?
| | Polylysine | 1 | 2001 | 17 | 0.050 |
Why?
| | Promoter Regions, Genetic | 2 | 2005 | 1198 | 0.050 |
Why?
| | Ischemia | 1 | 2024 | 395 | 0.040 |
Why?
| | Hedgehog Proteins | 1 | 2022 | 187 | 0.040 |
Why?
| | Indicators and Reagents | 1 | 2001 | 105 | 0.040 |
Why?
| | Crohn Disease | 1 | 2024 | 206 | 0.040 |
Why?
| | Drinking | 1 | 2021 | 40 | 0.040 |
Why?
| | Plant Oils | 1 | 2000 | 29 | 0.040 |
Why?
| | Ursodeoxycholic Acid | 1 | 2020 | 19 | 0.040 |
Why?
| | Intestine, Large | 1 | 2020 | 12 | 0.040 |
Why?
| | B7-H1 Antigen | 1 | 2022 | 189 | 0.040 |
Why?
| | Lymphocyte Activation | 1 | 2025 | 1098 | 0.040 |
Why?
| | Intercellular Junctions | 1 | 2020 | 39 | 0.040 |
Why?
| | Extracellular Matrix | 1 | 2024 | 495 | 0.040 |
Why?
| | C-Reactive Protein | 1 | 2023 | 397 | 0.040 |
Why?
| | Receptors, Purinergic P2X2 | 1 | 2020 | 14 | 0.040 |
Why?
| | Receptors, Purinergic P2X3 | 1 | 2020 | 13 | 0.040 |
Why?
| | Pyrones | 1 | 2020 | 9 | 0.040 |
Why?
| | Genes, Transgenic, Suicide | 1 | 2020 | 7 | 0.040 |
Why?
| | Forkhead Transcription Factors | 1 | 2021 | 182 | 0.040 |
Why?
| | Fluorescence | 1 | 2001 | 157 | 0.040 |
Why?
| | Dextran Sulfate | 1 | 2020 | 76 | 0.040 |
Why?
| | Morphogenesis | 1 | 2021 | 156 | 0.040 |
Why?
| | Streptococcus pneumoniae | 1 | 2022 | 159 | 0.040 |
Why?
| | Calcium | 1 | 2006 | 1178 | 0.040 |
Why?
| | Gene Knockdown Techniques | 1 | 2021 | 312 | 0.040 |
Why?
| | DNA-Binding Proteins | 2 | 2019 | 1421 | 0.040 |
Why?
| | Proteostasis | 1 | 2020 | 27 | 0.040 |
Why?
| | Leukocytes | 1 | 2022 | 303 | 0.040 |
Why?
| | Lactobacillus | 1 | 2020 | 26 | 0.040 |
Why?
| | Permeability | 1 | 2020 | 156 | 0.040 |
Why?
| | Cecum | 1 | 2020 | 32 | 0.040 |
Why?
| | Feeding Behavior | 2 | 2018 | 618 | 0.040 |
Why?
| | Antimetabolites, Antineoplastic | 1 | 2020 | 90 | 0.040 |
Why?
| | Cytomegalovirus | 1 | 2001 | 152 | 0.040 |
Why?
| | RNA | 2 | 2024 | 880 | 0.040 |
Why?
| | Epithelial-Mesenchymal Transition | 1 | 2022 | 199 | 0.040 |
Why?
| | Lysosomal-Associated Membrane Protein 2 | 1 | 2019 | 28 | 0.040 |
Why?
| | Receptors, Antigen, T-Cell | 1 | 2024 | 699 | 0.040 |
Why?
| | Ki-67 Antigen | 2 | 2016 | 107 | 0.040 |
Why?
| | R-SNARE Proteins | 1 | 2019 | 19 | 0.040 |
Why?
| | Biphenyl Compounds | 1 | 2020 | 64 | 0.040 |
Why?
| | Toll-Like Receptors | 1 | 2020 | 179 | 0.040 |
Why?
| | Cell Line, Tumor | 3 | 2016 | 3184 | 0.040 |
Why?
| | Purines | 1 | 2020 | 169 | 0.040 |
Why?
| | Chemokine CCL2 | 1 | 2020 | 118 | 0.040 |
Why?
| | Glomerular Filtration Rate | 1 | 2023 | 681 | 0.040 |
Why?
| | Pituitary Gland | 1 | 2020 | 148 | 0.040 |
Why?
| | Aging | 2 | 2024 | 1750 | 0.040 |
Why?
| | Binding Sites | 1 | 2003 | 1236 | 0.040 |
Why?
| | Thiophenes | 1 | 2020 | 118 | 0.040 |
Why?
| | Interleukin-1beta | 1 | 2021 | 373 | 0.040 |
Why?
| | Polymers | 2 | 2014 | 471 | 0.040 |
Why?
| | Interferon-alpha | 1 | 2020 | 192 | 0.040 |
Why?
| | Collagen Type I | 1 | 2020 | 117 | 0.040 |
Why?
| | Uncoupling Protein 1 | 1 | 2019 | 15 | 0.040 |
Why?
| | Iodide Peroxidase | 1 | 2019 | 28 | 0.040 |
Why?
| | Uterine Cervical Neoplasms | 1 | 2002 | 232 | 0.040 |
Why?
| | Food Preferences | 1 | 2020 | 112 | 0.040 |
Why?
| | Cyclin D1 | 1 | 2019 | 63 | 0.040 |
Why?
| | Photoperiod | 1 | 2019 | 46 | 0.040 |
Why?
| | Parasite Load | 1 | 2018 | 8 | 0.040 |
Why?
| | Leishmania donovani | 1 | 2018 | 7 | 0.040 |
Why?
| | Sirtuins | 1 | 2019 | 37 | 0.040 |
Why?
| | Drug Therapy, Combination | 1 | 2022 | 1009 | 0.040 |
Why?
| | Peptide Fragments | 1 | 2003 | 684 | 0.040 |
Why?
| | Alanine | 1 | 2019 | 141 | 0.040 |
Why?
| | gamma Catenin | 1 | 2018 | 13 | 0.040 |
Why?
| | Chemoprevention | 1 | 2019 | 90 | 0.040 |
Why?
| | Desmoglein 3 | 1 | 2018 | 16 | 0.040 |
Why?
| | Protein Binding | 3 | 2011 | 2103 | 0.040 |
Why?
| | Metaplasia | 1 | 2018 | 54 | 0.040 |
Why?
| | Bronchial Diseases | 1 | 2018 | 38 | 0.040 |
Why?
| | Apoptosis Regulatory Proteins | 1 | 2019 | 182 | 0.040 |
Why?
| | Mice, 129 Strain | 1 | 2018 | 79 | 0.040 |
Why?
| | Breast Neoplasms | 1 | 2010 | 2132 | 0.040 |
Why?
| | Sirtuin 3 | 1 | 2019 | 55 | 0.040 |
Why?
| | Ribosomes | 1 | 2019 | 164 | 0.040 |
Why?
| | Sarcopenia | 1 | 2019 | 74 | 0.040 |
Why?
| | Protein Transport | 1 | 2019 | 420 | 0.040 |
Why?
| | Cell Respiration | 1 | 2018 | 98 | 0.040 |
Why?
| | Cholic Acids | 1 | 2017 | 17 | 0.040 |
Why?
| | Single-Cell Analysis | 1 | 2020 | 272 | 0.040 |
Why?
| | Glomerular Mesangium | 1 | 2017 | 18 | 0.040 |
Why?
| | Cell Cycle Checkpoints | 1 | 2018 | 95 | 0.040 |
Why?
| | Oligonucleotides, Antisense | 1 | 1998 | 106 | 0.040 |
Why?
| | Azo Compounds | 1 | 2017 | 26 | 0.040 |
Why?
| | Adiponectin | 2 | 2013 | 234 | 0.040 |
Why?
| | Virulence | 1 | 2018 | 251 | 0.040 |
Why?
| | Xenograft Model Antitumor Assays | 1 | 2020 | 814 | 0.040 |
Why?
| | Mice, Inbred DBA | 1 | 2017 | 186 | 0.040 |
Why?
| | Heart Function Tests | 1 | 2017 | 59 | 0.040 |
Why?
| | Adenine | 1 | 2019 | 255 | 0.030 |
Why?
| | Sodium-Phosphate Cotransporter Proteins, Type I | 1 | 2017 | 1 | 0.030 |
Why?
| | HSP70 Heat-Shock Proteins | 1 | 2017 | 67 | 0.030 |
Why?
| | Urinalysis | 1 | 2017 | 69 | 0.030 |
Why?
| | Monocarboxylic Acid Transporters | 1 | 2017 | 20 | 0.030 |
Why?
| | Isoenzymes | 1 | 2018 | 304 | 0.030 |
Why?
| | Pyrazoles | 1 | 2020 | 404 | 0.030 |
Why?
| | Adaptive Immunity | 1 | 2018 | 157 | 0.030 |
Why?
| | Islets of Langerhans | 1 | 2003 | 790 | 0.030 |
Why?
| | Immunoenzyme Techniques | 2 | 2011 | 206 | 0.030 |
Why?
| | Models, Molecular | 2 | 2013 | 1480 | 0.030 |
Why?
| | Electron Transport Chain Complex Proteins | 1 | 2016 | 19 | 0.030 |
Why?
| | Podocytes | 1 | 2017 | 51 | 0.030 |
Why?
| | Erythema | 1 | 2017 | 28 | 0.030 |
Why?
| | Staining and Labeling | 2 | 1992 | 137 | 0.030 |
Why?
| | DNA | 5 | 1986 | 1390 | 0.030 |
Why?
| | Fibroblast Growth Factors | 1 | 2018 | 170 | 0.030 |
Why?
| | Adenosine Triphosphate | 1 | 2019 | 471 | 0.030 |
Why?
| | Bacteria | 1 | 2023 | 808 | 0.030 |
Why?
| | Indomethacin | 2 | 2006 | 77 | 0.030 |
Why?
| | Bronchi | 1 | 2018 | 240 | 0.030 |
Why?
| | Butyrophilins | 1 | 2016 | 6 | 0.030 |
Why?
| | Homeodomain Proteins | 1 | 2020 | 490 | 0.030 |
Why?
| | Inflammation Mediators | 1 | 2019 | 495 | 0.030 |
Why?
| | Albuminuria | 1 | 2017 | 181 | 0.030 |
Why?
| | Chromosomes, Artificial, Yeast | 1 | 1996 | 4 | 0.030 |
Why?
| | Intracellular Membranes | 1 | 2016 | 82 | 0.030 |
Why?
| | Okadaic Acid | 1 | 1996 | 14 | 0.030 |
Why?
| | Aspartate Aminotransferases | 1 | 2016 | 85 | 0.030 |
Why?
| | Hybrid Cells | 1 | 1996 | 50 | 0.030 |
Why?
| | Oxidoreductases | 1 | 2016 | 89 | 0.030 |
Why?
| | Connective Tissue | 1 | 2016 | 38 | 0.030 |
Why?
| | Sequence Homology, Nucleic Acid | 1 | 1996 | 150 | 0.030 |
Why?
| | Blood Glucose | 2 | 2018 | 2093 | 0.030 |
Why?
| | RNA-Binding Proteins | 1 | 2019 | 388 | 0.030 |
Why?
| | Tissue Array Analysis | 1 | 2016 | 57 | 0.030 |
Why?
| | Enzyme-Linked Immunosorbent Assay | 1 | 2018 | 815 | 0.030 |
Why?
| | Lentivirus | 1 | 2016 | 52 | 0.030 |
Why?
| | Recurrence | 1 | 2019 | 996 | 0.030 |
Why?
| | Golgi Apparatus | 1 | 1996 | 98 | 0.030 |
Why?
| | Systems Biology | 1 | 2016 | 59 | 0.030 |
Why?
| | Survival Rate | 1 | 2020 | 1869 | 0.030 |
Why?
| | Fatty Acids, Unsaturated | 1 | 2016 | 95 | 0.030 |
Why?
| | Genotype | 1 | 2020 | 1828 | 0.030 |
Why?
| | Glucose Intolerance | 1 | 2016 | 142 | 0.030 |
Why?
| | Calcium-Binding Proteins | 1 | 2016 | 210 | 0.030 |
Why?
| | Deoxyguanosine | 1 | 2015 | 24 | 0.030 |
Why?
| | Chemokine CXCL2 | 1 | 2014 | 43 | 0.030 |
Why?
| | Mutation, Missense | 1 | 2017 | 315 | 0.030 |
Why?
| | Chromosome Mapping | 1 | 1996 | 504 | 0.030 |
Why?
| | Catalysis | 1 | 2016 | 305 | 0.030 |
Why?
| | Receptor, Platelet-Derived Growth Factor beta | 1 | 2014 | 29 | 0.030 |
Why?
| | Tumor Burden | 1 | 2016 | 283 | 0.030 |
Why?
| | Proto-Oncogene Proteins | 1 | 2018 | 634 | 0.030 |
Why?
| | Biopsy | 1 | 2018 | 1081 | 0.030 |
Why?
| | Cytochrome P-450 CYP4A | 1 | 2014 | 4 | 0.030 |
Why?
| | Kidney Cortex | 1 | 2014 | 25 | 0.030 |
Why?
| | Cell Cycle Proteins | 1 | 2018 | 577 | 0.030 |
Why?
| | Comet Assay | 1 | 2014 | 17 | 0.030 |
Why?
| | Flow Cytometry | 1 | 2018 | 1142 | 0.030 |
Why?
| | Fatty Acid Synthases | 1 | 2014 | 24 | 0.030 |
Why?
| | T-Lymphocytes | 1 | 2022 | 1923 | 0.030 |
Why?
| | CD36 Antigens | 1 | 2014 | 35 | 0.030 |
Why?
| | Real-Time Polymerase Chain Reaction | 1 | 2015 | 324 | 0.030 |
Why?
| | Lipopolysaccharide Receptors | 1 | 2014 | 88 | 0.030 |
Why?
| | Electrocardiography | 1 | 2017 | 604 | 0.030 |
Why?
| | Matrix Metalloproteinases | 1 | 2014 | 89 | 0.030 |
Why?
| | Cell Line, Transformed | 1 | 2014 | 140 | 0.030 |
Why?
| | Protein Isoforms | 1 | 2015 | 378 | 0.030 |
Why?
| | RNA Interference | 1 | 2016 | 441 | 0.030 |
Why?
| | Leukocyte Count | 1 | 2014 | 325 | 0.030 |
Why?
| | Skinfold Thickness | 1 | 2013 | 46 | 0.030 |
Why?
| | Kinetics | 3 | 1987 | 1615 | 0.030 |
Why?
| | Progesterone | 2 | 1987 | 242 | 0.030 |
Why?
| | Exercise Therapy | 1 | 2018 | 413 | 0.030 |
Why?
| | In Situ Nick-End Labeling | 1 | 2013 | 120 | 0.030 |
Why?
| | Homocysteine S-Methyltransferase | 1 | 2013 | 5 | 0.030 |
Why?
| | Matrix Metalloproteinase 9 | 1 | 2014 | 112 | 0.030 |
Why?
| | Central Nervous System Depressants | 1 | 2014 | 82 | 0.030 |
Why?
| | Stress, Physiological | 1 | 2016 | 410 | 0.030 |
Why?
| | Tetraspanin 28 | 2 | 2005 | 6 | 0.030 |
Why?
| | Sequence Analysis, DNA | 1 | 1996 | 771 | 0.030 |
Why?
| | Tongue | 1 | 2013 | 71 | 0.030 |
Why?
| | Binding, Competitive | 3 | 1992 | 199 | 0.030 |
Why?
| | Basic Helix-Loop-Helix Leucine Zipper Transcription Factors | 1 | 2013 | 24 | 0.030 |
Why?
| | Cell Nucleus | 2 | 2009 | 578 | 0.030 |
Why?
| | Ketone Bodies | 1 | 2013 | 14 | 0.030 |
Why?
| | Nucleic Acid Conformation | 1 | 1996 | 706 | 0.030 |
Why?
| | Leydig Cells | 1 | 1992 | 13 | 0.030 |
Why?
| | Computational Biology | 1 | 2017 | 598 | 0.030 |
Why?
| | Antigens, CD1d | 1 | 2013 | 66 | 0.030 |
Why?
| | Aldehyde Reductase | 1 | 2013 | 27 | 0.030 |
Why?
| | RNA, Ribosomal, 16S | 1 | 2015 | 519 | 0.030 |
Why?
| | Transcriptome | 1 | 2019 | 881 | 0.030 |
Why?
| | Theca Cells | 1 | 1992 | 1 | 0.030 |
Why?
| | Antibody Specificity | 1 | 1993 | 182 | 0.030 |
Why?
| | Antibodies | 1 | 2014 | 391 | 0.030 |
Why?
| | Nerve Tissue Proteins | 1 | 2016 | 567 | 0.030 |
Why?
| | Species Specificity | 1 | 2013 | 568 | 0.020 |
Why?
| | Models, Chemical | 1 | 2014 | 263 | 0.020 |
Why?
| | Actins | 1 | 2014 | 401 | 0.020 |
Why?
| | Infant, Newborn | 2 | 2019 | 5687 | 0.020 |
Why?
| | Dietary Supplements | 1 | 2016 | 531 | 0.020 |
Why?
| | Follow-Up Studies | 1 | 2021 | 4892 | 0.020 |
Why?
| | alpha-Macroglobulins | 1 | 2012 | 24 | 0.020 |
Why?
| | Models, Biological | 2 | 2011 | 1691 | 0.020 |
Why?
| | Sex Factors | 1 | 2018 | 1945 | 0.020 |
Why?
| | Prognosis | 1 | 2020 | 3772 | 0.020 |
Why?
| | Caseins | 1 | 2011 | 18 | 0.020 |
Why?
| | Palmitic Acid | 1 | 2011 | 40 | 0.020 |
Why?
| | Amino Acids | 1 | 2015 | 474 | 0.020 |
Why?
| | Chromatography, High Pressure Liquid | 1 | 2013 | 475 | 0.020 |
Why?
| | Prenatal Exposure Delayed Effects | 1 | 2018 | 563 | 0.020 |
Why?
| | Enzyme Activation | 1 | 2013 | 799 | 0.020 |
Why?
| | Survival Analysis | 1 | 2014 | 1263 | 0.020 |
Why?
| | Serum Albumin | 1 | 2012 | 145 | 0.020 |
Why?
| | Body Temperature | 1 | 2012 | 212 | 0.020 |
Why?
| | Mucous Membrane | 2 | 2002 | 120 | 0.020 |
Why?
| | Lipase | 1 | 2011 | 64 | 0.020 |
Why?
| | Retinal Dehydrogenase | 1 | 2011 | 33 | 0.020 |
Why?
| | Insulin | 2 | 2016 | 2315 | 0.020 |
Why?
| | Membranes, Artificial | 1 | 2011 | 69 | 0.020 |
Why?
| | Antineoplastic Agents | 1 | 2022 | 2051 | 0.020 |
Why?
| | Tritium | 1 | 1990 | 75 | 0.020 |
Why?
| | Chromatography, Affinity | 1 | 1990 | 83 | 0.020 |
Why?
| | Cations, Divalent | 1 | 1990 | 54 | 0.020 |
Why?
| | Baculoviridae | 1 | 2010 | 44 | 0.020 |
Why?
| | Blood Pressure | 1 | 2017 | 1728 | 0.020 |
Why?
| | Mitochondria, Liver | 1 | 2010 | 73 | 0.020 |
Why?
| | Microscopy, Electron, Transmission | 1 | 2010 | 142 | 0.020 |
Why?
| | Insecta | 1 | 2010 | 64 | 0.020 |
Why?
| | Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 1 | 2010 | 136 | 0.020 |
Why?
| | Hydrolysis | 1 | 1990 | 184 | 0.020 |
Why?
| | Oxidants | 1 | 2010 | 106 | 0.020 |
Why?
| | NAD | 1 | 2010 | 72 | 0.020 |
Why?
| | Cell Death | 1 | 2011 | 348 | 0.020 |
Why?
| | Cytosol | 1 | 2010 | 214 | 0.020 |
Why?
| | Urokinase-Type Plasminogen Activator | 1 | 2009 | 29 | 0.020 |
Why?
| | Histones | 1 | 2015 | 586 | 0.020 |
Why?
| | Transgenes | 1 | 2010 | 176 | 0.020 |
Why?
| | Hypoxia | 1 | 2016 | 1036 | 0.020 |
Why?
| | Protease Inhibitors | 1 | 1990 | 104 | 0.020 |
Why?
| | Seasons | 1 | 2012 | 497 | 0.020 |
Why?
| | HeLa Cells | 2 | 2001 | 603 | 0.020 |
Why?
| | Administration, Inhalation | 1 | 2011 | 661 | 0.020 |
Why?
| | In Vitro Techniques | 2 | 1989 | 1039 | 0.020 |
Why?
| | Culture Media, Conditioned | 1 | 2009 | 108 | 0.020 |
Why?
| | Plasmids | 1 | 2010 | 354 | 0.020 |
Why?
| | Prostaglandins F, Synthetic | 1 | 1989 | 9 | 0.020 |
Why?
| | Proliferating Cell Nuclear Antigen | 1 | 2008 | 50 | 0.020 |
Why?
| | Proto-Oncogene Proteins c-met | 1 | 2009 | 74 | 0.020 |
Why?
| | Administration, Topical | 1 | 2008 | 143 | 0.020 |
Why?
| | Neutrophil Infiltration | 1 | 2008 | 103 | 0.020 |
Why?
| | Nuclear Proteins | 1 | 2013 | 657 | 0.020 |
Why?
| | Administration, Oral | 1 | 2010 | 754 | 0.020 |
Why?
| | Cell Adhesion | 1 | 2009 | 445 | 0.020 |
Why?
| | Muscle, Skeletal | 1 | 2018 | 1628 | 0.020 |
Why?
| | Random Allocation | 1 | 2008 | 343 | 0.020 |
Why?
| | Palmitates | 1 | 2007 | 18 | 0.020 |
Why?
| | Cell Movement | 2 | 2009 | 936 | 0.020 |
Why?
| | Mice, Mutant Strains | 1 | 2007 | 292 | 0.020 |
Why?
| | Neoplasm Metastasis | 1 | 2009 | 608 | 0.020 |
Why?
| | Reflex, Stretch | 1 | 2006 | 10 | 0.020 |
Why?
| | Stearoyl-CoA Desaturase | 1 | 2007 | 62 | 0.020 |
Why?
| | Phosphatidylinositol Diacylglycerol-Lyase | 1 | 1986 | 4 | 0.020 |
Why?
| | Vanadium | 1 | 1986 | 4 | 0.020 |
Why?
| | Carbachol | 1 | 1986 | 20 | 0.020 |
Why?
| | Vanadates | 1 | 1986 | 14 | 0.020 |
Why?
| | Exercise | 1 | 2018 | 1929 | 0.020 |
Why?
| | Sequence Alignment | 1 | 2007 | 329 | 0.020 |
Why?
| | Prostaglandins E | 1 | 1986 | 47 | 0.020 |
Why?
| | Thymidine | 1 | 1986 | 59 | 0.020 |
Why?
| | Aged, 80 and over | 1 | 2018 | 7033 | 0.020 |
Why?
| | Phosphoric Diester Hydrolases | 1 | 1986 | 46 | 0.020 |
Why?
| | Substrate Specificity | 1 | 2007 | 365 | 0.020 |
Why?
| | Growth Substances | 1 | 1986 | 150 | 0.020 |
Why?
| | Phosphodiesterase Inhibitors | 1 | 1986 | 85 | 0.020 |
Why?
| | Infant | 1 | 2019 | 8914 | 0.020 |
Why?
| | PPAR gamma | 1 | 2007 | 182 | 0.020 |
Why?
| | Analysis of Variance | 1 | 2008 | 1269 | 0.020 |
Why?
| | Tetraspanins | 1 | 2005 | 15 | 0.020 |
Why?
| | Epidermal Growth Factor | 1 | 1986 | 170 | 0.020 |
Why?
| | Dinoprostone | 1 | 1986 | 187 | 0.020 |
Why?
| | Detergents | 1 | 2005 | 45 | 0.020 |
Why?
| | Antibodies, Viral | 1 | 2009 | 601 | 0.020 |
Why?
| | Peptide Hydrolases | 1 | 1986 | 105 | 0.020 |
Why?
| | Cyclic AMP | 1 | 1986 | 229 | 0.020 |
Why?
| | Uteroglobin | 2 | 1984 | 21 | 0.010 |
Why?
| | Solubility | 1 | 2005 | 229 | 0.010 |
Why?
| | Hydrocortisone | 1 | 1987 | 304 | 0.010 |
Why?
| | Genetic Predisposition to Disease | 1 | 2013 | 2264 | 0.010 |
Why?
| | Introns | 1 | 2005 | 249 | 0.010 |
Why?
| | Multiprotein Complexes | 1 | 2005 | 147 | 0.010 |
Why?
| | Child, Preschool | 1 | 2018 | 10384 | 0.010 |
Why?
| | Testosterone | 1 | 1987 | 373 | 0.010 |
Why?
| | Metformin | 1 | 2007 | 312 | 0.010 |
Why?
| | Glucagon | 1 | 2003 | 105 | 0.010 |
Why?
| | Tumor Virus Infections | 1 | 2002 | 45 | 0.010 |
Why?
| | Spectrometry, Fluorescence | 2 | 1979 | 170 | 0.010 |
Why?
| | Uterine Cervical Dysplasia | 1 | 2002 | 43 | 0.010 |
Why?
| | Fibroblasts | 1 | 2007 | 935 | 0.010 |
Why?
| | In Situ Hybridization | 1 | 2002 | 292 | 0.010 |
Why?
| | Papillomaviridae | 1 | 2002 | 113 | 0.010 |
Why?
| | Photochemistry | 2 | 1992 | 131 | 0.010 |
Why?
| | Fluorescent Dyes | 2 | 1979 | 311 | 0.010 |
Why?
| | Sheep | 3 | 1992 | 828 | 0.010 |
Why?
| | Membrane Microdomains | 1 | 2000 | 31 | 0.010 |
Why?
| | Polyribosomes | 1 | 1980 | 21 | 0.010 |
Why?
| | Molecular Structure | 2 | 1992 | 464 | 0.010 |
Why?
| | Macromolecular Substances | 1 | 2000 | 211 | 0.010 |
Why?
| | Hyperplasia | 1 | 2001 | 170 | 0.010 |
Why?
| | Keratins | 1 | 2001 | 175 | 0.010 |
Why?
| | Gestational Age | 1 | 2003 | 867 | 0.010 |
Why?
| | DNA, Viral | 1 | 2002 | 348 | 0.010 |
Why?
| | Thyrotropin | 1 | 1980 | 109 | 0.010 |
Why?
| | Thyroid Gland | 1 | 1980 | 94 | 0.010 |
Why?
| | Cytological Techniques | 1 | 1979 | 26 | 0.010 |
Why?
| | Adolescent | 1 | 2018 | 20179 | 0.010 |
Why?
| | Chromomycins | 1 | 1978 | 1 | 0.010 |
Why?
| | Olivomycins | 1 | 1978 | 1 | 0.010 |
Why?
| | Plicamycin | 1 | 1978 | 3 | 0.010 |
Why?
| | Fetus | 1 | 2003 | 760 | 0.010 |
Why?
| | Child | 1 | 2018 | 20655 | 0.010 |
Why?
| | Papillomavirus Infections | 1 | 2002 | 290 | 0.010 |
Why?
| | Hypoglycemic Agents | 1 | 2007 | 1212 | 0.010 |
Why?
| | Peptides, Cyclic | 1 | 1978 | 255 | 0.010 |
Why?
| | Cell Cycle | 1 | 1978 | 581 | 0.010 |
Why?
| | Polyethylene Glycols | 1 | 2000 | 596 | 0.010 |
Why?
| | Luteal Cells | 1 | 1992 | 2 | 0.010 |
Why?
| | Esters | 1 | 1992 | 74 | 0.010 |
Why?
| | Chemistry | 1 | 1989 | 42 | 0.000 |
Why?
| | Chemical Phenomena | 1 | 1989 | 80 | 0.000 |
Why?
| | Estrogen Antagonists | 1 | 1984 | 45 | 0.000 |
Why?
| | Poly A | 1 | 1980 | 48 | 0.000 |
Why?
| | RNA, Ribosomal | 1 | 1980 | 162 | 0.000 |
Why?
| | Fixatives | 1 | 1978 | 14 | 0.000 |
Why?
| | Leukemia, Experimental | 1 | 1978 | 27 | 0.000 |
Why?
| | Osmolar Concentration | 1 | 1978 | 164 | 0.000 |
Why?
| | Cricetinae | 1 | 1978 | 275 | 0.000 |
Why?
| | Magnesium | 1 | 1978 | 150 | 0.000 |
Why?
| | Hydrogen-Ion Concentration | 1 | 1978 | 536 | 0.000 |
Why?
|
|
Orlicky's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|